Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

NCT01689155 · clinicaltrials.gov ↗

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Infection

Interventions

BIOLOGICAL: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company